Catalyst Pharmaceuticals, Inc.

做多

Buy Today

CPRX is a buy! Good P/E Ratio with a good growth profile. Stock is down because of the lawsuit which is not really a true competition.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。